Made O'Meter
Discover where a brand or product originates
Bivacyn belongs to Sandoz Group AG through Lek Pharmaceuticals d.d.. Bivacyn is owned by Sandoz Group AG, headquartered in Switzerland. No. The ultimate owner of Bivacyn, Sandoz Group AG, is headquartered in Switzerland, not in the United States.
Sandoz is a global leader in generic and biosimilar pharmaceuticals, recently spun off as an independent entity from Novartis in 2023.
Lek Pharmaceuticals d.d.
Sources: sandoz.com, lek.si
Check another productdisclaimer
poweredBy